Novel FGFR4-Targeting Single-Domain Antibodies for Multiple Targeted Therapies against Rhabdomyosarcoma.
Alijaj N, Moutel S, Gouveia ZL, Gray M, Roveri M, Dzhumashev D, Weber F, Meier G, Luciani P, Rössler JK, Schäfer BW, Perez F, Bernasconi M.
Alijaj N, et al. Among authors: perez f.
Cancers (Basel). 2020 Nov 10;12(11):3313. doi: 10.3390/cancers12113313.
Cancers (Basel). 2020.
PMID: 33182650
Free PMC article.